Emergent BioSolutions (EBS) Deferred Taxes (2010 - 2026)
Emergent BioSolutions (EBS) posted quarterly Deferred Taxes of -$4.5 million for Q1 2026, down 124.19% year-over-year from $18.6 million in Q1 2025, and down 400.0% quarter-over-quarter from $1.5 million in Q4 2025.
Emergent BioSolutions (EBS) Deferred Taxes (2010 - 2026) Analysis & Trends
Emergent BioSolutions' Deferred Taxes history runs 17 years deep, the most recent figure standing at -$4.5 million for Q1 2026.
- In Q1 2026, Deferred Taxes fell 124.19% year-over-year to -$4.5 million; the TTM figure through Mar 2026 stood at -$27.1 million (down 207.11% YoY), while the FY2025 annual figure was -$4.0 million, up 27.27% from the prior year.
- Deferred Taxes for Q1 2026 stood at -$4.5 million, down from $1.5 million in the prior quarter.
- The five-year high for Deferred Taxes was $22.9 million in Q3 2022, with the low at -$54.1 million in Q4 2022.
- The 5-year median for Deferred Taxes is -$400000.0 (2024), against an average of -$3.0 million.
- The sharpest annual moves came in 2022 and 2025: Deferred Taxes soared 502.63% in 2022, then slumped 6850.0% in 2025.
- Emergent BioSolutions' Deferred Taxes stood at -$54.1 million in 2022, then jumped by 90.39% to -$5.2 million in 2023, then soared by 92.31% to -$400000.0 in 2024, then soared by 475.0% to $1.5 million in 2025, then plunged by 400.0% to -$4.5 million in 2026.
- Business Quant data shows EBS's Deferred Taxes at -$4.5 million in Q1 2026, $1.5 million in Q4 2025, and -$10.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.16 Bn | 43.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.86 Bn | 40.20 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 32.53 Bn | 30.86 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.34 Bn | 19.68 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.89 Bn | 18.00 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Emergent BioSolutions | 252.84 Mn | 111.94 Mn | 137.20 Mn | 2.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.10 Mn |
| Mar 31, 2026 | -4.50 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | -10.20 Mn |
| Jun 30, 2025 | -13.90 Mn |
| Mar 31, 2025 | 18.60 Mn |
| Dec 31, 2024 | -400,000.00 |
| Sep 30, 2024 | 7.30 Mn |
| Jun 30, 2024 | -200,000.00 |
| Mar 31, 2024 | -12.20 Mn |
| Dec 31, 2023 | -5.20 Mn |
| Sep 30, 2023 | 2.70 Mn |
| Jun 30, 2023 | -1.70 Mn |
| Mar 31, 2023 | -4.70 Mn |
| Dec 31, 2022 | -54.10 Mn |
| Sep 30, 2022 | 22.90 Mn |
| Jun 30, 2022 | 700,000.00 |
| Mar 31, 2022 | 1.90 Mn |
| Dec 31, 2021 | 45.40 Mn |
| Sep 30, 2021 | 3.80 Mn |